The National Drug Code (NDC) for Kenalog in 2023 is not a single, static number. Instead, NDCs are assigned to specific drug packaging configurations, meaning different strengths, forms, and package sizes of Kenalog will have distinct NDC codes [1].
What is an NDC code?
An NDC code is a unique 10- or 11-digit identifier assigned by the U.S. Food and Drug Administration (FDA) to human drugs for sale in the United States [2]. It consists of three segments: the first segment identifies the manufacturer, the second identifies the product, and the third identifies the package size [3]. This system helps in the identification, reporting, and payment of drug claims [1].
How to find the NDC for a specific Kenalog product
To find the NDC for a specific Kenalog product, you would need to refer to the drug's packaging [1]. The NDC is typically printed on the drug label or carton. For example, a particular formulation of Kenalog might have an NDC like 0003-0525-01, where 0003 represents the manufacturer (likely Bristol-Myers Squibb, a historically significant manufacturer of Kenalog), 0525 identifies the specific product, and 01 indicates the package size [1][3].
What are the different forms of Kenalog?
Kenalog is a brand name for triamcinolone acetonide, a corticosteroid. It is available in various forms, including injectable suspensions for intra-articular and intramuscular use, topical creams and ointments, and nasal sprays. Each of these forms, and their respective strengths and package sizes, will have its own unique NDC code [1].
When does patent protection for Kenalog expire?
Information regarding specific patent expiration dates for brand-name drugs like Kenalog is often tracked by resources specializing in pharmaceutical patents. These dates are crucial for determining when generic versions of the drug can enter the market [4]. For detailed patent information and expiration timelines, resources like DrugPatentWatch.com can provide comprehensive data [4].
Who manufactures Kenalog?
The original manufacturer of Kenalog is Bristol-Myers Squibb. However, as patents expire, other pharmaceutical companies may produce and market generic versions of triamcinolone acetonide, each with their own NDCs and potentially under different brand names [1].
Sources:
[1] U.S. Food and Drug Administration. (n.d.). National Drug Code (NDC) Directory. Retrieved from https://www.fda.gov/drugs/national-drug-code-directory/national-drug-code-ndc-directory
[2] U.S. Food and Drug Administration. (n.d.). What is the National Drug Code (NDC)? Retrieved from https://www.fda.gov/drugs/drug-labeling-and-packaging/what-national-drug-code-ndc
[3] U.S. Food and Drug Administration. (n.d.). NDC: The 11-Digit National Drug Code. Retrieved from https://www.fda.gov/drugs/drug-labeling-and-packaging/ndc-11-digit-national-drug-code
[4] DrugPatentWatch.com. (n.d.). Drug Patent Information. Retrieved from https://drugpatentwatch.com/